Table 2. Subgroup-analysis of the association between β-catenin expression in different subcellular location and survival.
Subgroup | No. of studies | HR (95% CI) | Heterogeneity | |
---|---|---|---|---|
I2 (%) | P | |||
Membrane (18,28,30,34,36-38) | ||||
Overall effect | 7 | 0.53 (0.32–0.87) | 78.6 | 0.000 |
Analysis model | ||||
Univariate | 3 | 0.38 (0.24–0.60) | 0.0 | 0.863 |
Multivariate | 4 | 0.64 (0.33–1.21) | 84.0 | 0.000 |
HR estimate | ||||
Reported in text | 4 | 0.59 (0.33–1.04) | 81.7 | 0.000 |
By estimate | 2 | 0.36 (0.32–0.64) | 0.0 | 0.653 |
Patients’ number | ||||
<100 | 4 | 0.41 (0.30–0.57) | 0.0 | 0.907 |
≥100 | 3 | 0.72 (0.34–1.53) | 81.3 | 0.005 |
Study location | ||||
Asia | 6 | 0.57 (0.34–0.97) | 78.7 | 0.000 |
Non-Asia | 1 | 0.31 (0.14–0.68) | ||
Cytoplasm (18,25-27,33) | ||||
Overall effect | 10 | 1.64 (1.34–1.99) | 36.5 | 0.116 |
Analysis model | ||||
Univariate | 4 | 1.35 (1.00–1.86) | 36.6 | 0.192 |
Multivariate | 6 | 1.85 (1.43–2.38) | 31.1 | 0.202 |
HR estimate | ||||
Reported in text | 9 | 1.64 (1.33–2.01) | 43.6 | 0.077 |
By estimate | 1 | 1.62 (0.83–3.17) | ||
Patients’ number | ||||
<100 | 4 | 1.75 (0.98–3.12) | 0.0 | 0.412 |
≥100 | 6 | 1.62 (1.32–2.00) | 55.6 | 0.047 |
Study location | ||||
Asia | 8 | 1.60 (1.30–1.97) | 40.5 | 0.108 |
Non-Asia | 2 | 2.05 (1.05–3.99) | 48.2 | 0.165 |
Abnormal expression (17,29,31,32,35) | ||||
Overall effect | 5 | 1.38 (0.61–3.15) | ||
Patients’ number | ||||
<100 | 1 | 6.29 (0.71–55.56) | ||
≥100 | 4 | 1.18 (0.50–2.77) | 80.1 | 0.002 |
CI, confidence interval; HR, hazard ratio.